News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Rob Sahr

Advertisement

Articles by Rob Sahr

Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patenting

ByRob Sahr,Kady Bruce, Wolf Greenfield
January 28th 2021

Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another

Advertisement

Latest Updated Articles

  • Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patenting
    Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patenting

    Published: January 28th 2021 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

GoodRx Offers FDA-Approved Wegovy Pill at $149 Monthly Cash Price Across US Pharmacies

2

Pharma Pulse: GoodRx Rollout for Oral Wegovy; Major Reprieve for 340B Hospitals; Sanofi’s $2.5B AI Bet

3

What the Closure of a Single Plant Reveals About US Drug Resilience

4

How Public Policy Shifts Are Reshaping Employer Healthcare Costs

5

Employer Health Costs Rise, as Drug Innovation, Behavioral Health, and Hospital Dynamics Converge

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us